Accumetrics, a privately-held developer and marketer of the VerifyNow System, a diagnostic system for measuring platelet reactivity to multiple antiplatelet agents, has signed a new agreement with Medico’s Hirata for distribution of its VerifyNow System in Japan.
Accumetrics VerifyNow System helps physicians assess patients’ response to all major antiplatelet therapies such as aspirin, Ticlid, Plavix, Effient and GP IIb/IIIa inhibitors. As response to these drugs varies, the tests help physicians ensure their patients on antiplatelet therapies are receiving the optimal benefit.
Timothy Still, president and CEO of Accumetrics, said: “Partnering with Medico’s Hirata, one of the largest medical device distributors in Japan, is an integral element of our international expansion strategy.”
Masataka Hirata, president of Medico’s Hirata, said: “With our 90-strong direct sales organization, coupled with a large distribution network and experienced marketing and regulatory teams, we are well-positioned to bring personalized antiplatelet testing to Japan’s physicians.”